TITLE

Medical oncology

PUB. DATE
August 1997
SOURCE
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS60
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Presents an abstract of the research manuscript `Changes in physical performance during adjuvant chemotherapy for breast cancer in postmenopausal women,' by J.M. Watters et al.
ACCESSION #
9708236662

 

Related Articles

  • Routine zoledronic acid use not supported in early breast cancer. McSweeny, Linda // Medical Journal of Australia;10/17/2011, Vol. 195 Issue 8, p439 

    The article focuses on an open-label phase three randomised trial which suggests that the routine zoledronic acid use in the adjuvant treatment of early-stage breast cancer is not supported.

  • A surgical subculture. Starreveld, Adalei // CMAJ: Canadian Medical Association Journal;01/01/97, Vol. 156 Issue 1, p43 

    Editorial. Comments on the inconsistent results of the studies on the use of the breast-conserving surgery to treat breast cancer. Limited role of adjuvant treatment in reducing the rates of local recurrence; Lack of consistency in the extent of surgery and radiation therapy. Suggestions for...

  • Radiation oncology.  // Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS91 

    Presents an abstract of the research manuscript `Is 4000 cGY in 16 fractions adequate for local control in the adjuvant treatment of early breast cancer?,' by J. Yamada et al.

  • CORRESPONDENCE. Marcus, Richard; Holland, James; Green, A.; Hamblin, Terry J.; Morrison, J.M.; Monypenny, I.J.; Arkell, D.G.; Ryan, B.J.; Senapati, Asha; Stevenson, David; Pilsworth, Roy; Peters, J.L.; Fisher, C.; Mehtar, S.; Swift, C.; Malhotra, S.L.; Murray, Elizabeth D.S.; Hughes-Davies, T.H. // British Medical Journal (Clinical Research Edition);1/17/1981, Vol. 282 Issue 6259, p220 

    Comments on several issues related to medicine in Great Britain. Initiative to breast cancer trials; Side effects of adjuvant therapy for breast cancer; Decline of high density lipoprotein cholesterol concentrations in people with a high dietary sugar.

  • Adjuvant Therapy for Women Over Age 65 With Breast Cancer. Sautter-Bihl, Marie-Luise; Souchon, Rainer; Gerber, Bernd // Deutsches Aerzteblatt International;5/27/2011, Vol. 108 Issue 21, following p371 

    A bibliography on the subject of adjuvant therapy for women over age 65 with breast cancer is presented which includes the articles "Treatment of breast cancer in older women," by Bernardi D. and colleagues, "Acute toxicity of curative radiotherapy in elderly patients," by Huguenin P. and...

  • National Institute of Health Consensus Development Conference Statement: Adjuvant Therapy for....  // JNCI: Journal of the National Cancer Institute;7/14/2001, Vol. 93 Issue 13, p979 

    Focuses on the conference statement on the use of adjuvant therapy for breast cancer in the United States. Aims of the National Institutes of Health Consensus Development conference; Availability of adjuvant therapy to women with tumors expressing hormone receptor protein; Inclusion of...

  • Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy. Kyung-Hun Lee; Seock-Ah Im; Do-Youn Oh; Se-Hoon Lee; Eui Kyu Chie; Wonshik Han; Dong-Wan Kim; Tae-You Kim; In Ae Park; Dong-Young Noh; Dae Seog Heo; Sung Whan Ha; Yung-Jue Bang // BMC Cancer;2007, Vol. 7, p63 

    Background: Bcl-2 is positively regulated by hormonal receptor pathways in breast cancer. A study was conducted to assess the prognostic significances of clinico-pathologic variables and of ER, PR, p53, c-erbB2, bcl-2, or Ki-67 as markers of relapse in breast cancer patients who had received the...

  • Adjuvant breast cancer chemotherapy during late-trimester pregnancy: not quite a standard of care. Epstein, Richard J. // BMC Cancer;2007, Vol. 7, p92 

    Background: Diagnosis of breast cancer during pregnancy was formerly considered an indication for abortion. The pendulum has since swung to the other extreme, with most reviews now rejecting termination while endorsing immediate anthracycline-based therapy for any pregnant patient beyond the...

  • External influences and priority-setting for anti-cancer agents: a case study of media coverage in adjuvant trastuzumab for breast cancer. Booth, Christopher M.; Dranitsaris, George; Gainford, M. Corona; Berry, Scott; Fralick, Michael; Fralick, John; Sue, Joanna; Clemons, Mark // BMC Cancer;2007, Vol. 7, p110 

    Background: Setting priorities for the funding of new anti-cancer agents is becoming increasingly complex. The funding of adjuvant trastuzumab for breast cancer has brought this dilemma to the fore. In this paper we review external factors that may influence decision-making bodies and present a...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics